about
Cognition enhancers between treating and doping the mindIncrease of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memoryHomeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survivalMenopause and estrogen deficiency as a risk factor in dementing illness: hypothesis on the biological basis.Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism.Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state?Conformational altered p53 as an early marker of oxidative stress in Alzheimer's diseaseDual effect of beta-amyloid on α7 and α4β2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus.Bladder instability: a re-appraisal of classical experimental approaches and development of new therapeutic strategies.Autophagy activation clears ELAVL1/HuR-mediated accumulation of SQSTM1/p62 during proteasomal inhibition in human retinal pigment epithelial cellsThe pharmacology of amyloid precursor protein processing.Emerging targets for the pharmacology of learning and memory.Acetylcholinesterase inhibitors: novel activities of old molecules.Expression and activation of SH2/PTB-containing ShcA adaptor protein reflects the pattern of neurogenesis in the mammalian brain.The aging brain, a key target for the future: the protein kinase C involvement.Alzheimer's disease: new diagnostic and therapeutic toolsConformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression.Conformationally altered p53: a putative peripheral marker for Alzheimer's disease.Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53.Depression and antidepressants: molecular and cellular aspects.Senescence of the brain: focus on cognitive kinases.The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders.Awakenings and awareness recovery in disorders of consciousness: is there a role for drugs?Phosphorylation of APP-CTF-AICD domains and interaction with adaptor proteins: signal transduction and/or transcriptional role--relevance for Alzheimer pathology.How and why to screen for CYP2D6 interindividual variability in patients under pharmacological treatments.NGF and heart: Is there a role in heart disease?The complex world of post-transcriptional mechanisms: is their deregulation a common link for diseases? Focus on ELAV-like RNA-binding proteins.Pentraxins and Alzheimer's disease: at the interface between biomarkers and pharmacological targets.p53 at the crossroads between cancer and neurodegeneration.Protecting the retinal neurons from glaucoma: lowering ocular pressure is not enough.Do we need pharmacogenetics to personalize antidepressant therapy?Novel approaches to the post-myocardial infarction/heart failure neural remodeling.Functional mapping of the promoter region of the GNB2L1 human gene coding for RACK1 scaffold protein.Neuronal control of brain microvessel function.Modulation of Rack-1/PKCβII signalling by soluble AβPPα in SH-SY5Y cells.The C1 domain-targeted isophthalate derivative HMI-1b11 promotes neurite outgrowth and GAP-43 expression through PKCα activation in SH-SY5Y cells.Identification of peptides with ELAV-like mRNA-stabilizing effect: an integrated in vitro/in silico approach.Zyxin is a novel target for β-amyloid peptide: characterization of its role in Alzheimer's pathogenesis.Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.Cytoprotective response induced by electromagnetic stimulation on SH-SY5Y human neuroblastoma cell line.
P50
Q28273261-841C1C5A-84F4-41DC-9F40-614A6050DD27Q28578336-C6EBA123-8CC2-4770-B90B-CD4E194CC071Q33564142-655A7012-B0D5-478B-8F9A-C9E8F8E7FCE7Q33607450-F658DB47-8E97-469F-9072-BB554D555759Q33739400-D7DE4424-97E9-4A97-AE41-EB58366E2535Q34078777-8766DC44-D093-465F-9322-3D80DABCB888Q34126651-BAEA1731-D049-4665-8A9B-F84E263A9004Q34130551-E36E50C8-DED1-4ABA-B22D-0E7197F7FB7AQ34746996-EBA59C0A-3886-4808-9DEC-890746E184B7Q34903032-05B3E605-E431-44E8-8586-E568711106F3Q35051367-9B076731-36F8-48D6-9FD1-D8677A941FA0Q35792136-3AF64C5D-EE29-49ED-9F95-A7E6DD8A0EC3Q35860291-3AD35D53-BEDB-478B-86C9-048377D9A768Q36304091-E426840C-F0E4-45D4-A183-4B6B48DB8062Q36842183-DAC424A5-6DDD-4649-93C4-6E03ED156FE8Q36865357-E7301AB8-9075-408B-9748-14C2F8F6602DQ37073657-A24EFC37-20A9-4B9D-9535-BFBF7B84E882Q37103053-569BF231-B329-4C4D-A73D-0C93880A7685Q37367277-DD4B6A81-F164-4BCA-B617-8EDF623661F4Q37517285-E276F916-4689-4F42-9157-990017E5F459Q37730134-4AD6391B-D1F7-450F-B5C6-C610FFD8EC1FQ37730145-5AC1E187-2EE0-42E6-B625-AB0570CC741DQ37775609-E228D184-3406-4265-B1D2-C75BF71FC86CQ37805574-3079138E-770A-4D68-B3D6-4145A00FF4C3Q37822389-269F88F4-4065-4E18-A027-4F473D81360BQ37824971-D3258856-5774-4D64-96BE-09F67AF84DDEQ37930474-C7B8C038-2D33-493C-AE93-C99BDB372BF4Q37970208-10F9117B-51B3-4BAE-8D32-C0D44842E807Q37990283-8529A29B-532A-46CF-91A3-C534B7EC1811Q37995377-CB0666A9-A182-447A-A937-0BAD80CBB813Q38070163-CD1C8C7E-CDBA-4E91-8AFD-45343D812210Q38167632-9DC8DAE5-A98D-49F8-9529-87436CEAB31AQ38359135-4882AAA8-F9F5-47CF-B051-6DA82A4F034BQ38390480-428256CE-0C0B-45F3-BF1B-5F22647C4F82Q39117116-7F949A4F-AB44-43BC-8FC4-56D6A47629CBQ39156422-BA8E98B3-226D-4B7C-8F41-1E5D9C41C57CQ39196694-397EFDEB-D426-4157-886C-BE2DA9B46A7EQ39208501-FD7598F8-1E52-4613-A6AB-2F7E2408EFE0Q39210844-29B89A46-C8AA-495B-AC65-80CE1828848EQ39536042-6DCA1F2F-9A34-46C3-8F15-5D1350168D87
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Stefano Govoni
@ast
Stefano Govoni
@en
Stefano Govoni
@es
Stefano Govoni
@nl
Stefano Govoni
@sl
type
label
Stefano Govoni
@ast
Stefano Govoni
@en
Stefano Govoni
@es
Stefano Govoni
@nl
Stefano Govoni
@sl
prefLabel
Stefano Govoni
@ast
Stefano Govoni
@en
Stefano Govoni
@es
Stefano Govoni
@nl
Stefano Govoni
@sl
P1006
P214
P1006
P1053
K-2965-2015
P106
P1153
8159178800
P1960
zXb4VoMAAAAJ
P21
P214
P2798
P31
P3829
P496
0000-0002-7243-6837
P569
1950-07-13T00:00:00Z
P735
P7859
lccn-n86105290